| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/03/2007 | CA2627653A1 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists |
| 05/03/2007 | CA2627640A1 Therapeutic drug for suppressing functions of nkt cells containing glycolipid derivative as active ingredient |
| 05/03/2007 | CA2627608A1 Micronised azodicarbonamide, the preparation and use thereof |
| 05/03/2007 | CA2627497A1 Heterocyclic amide compound and use thereof |
| 05/03/2007 | CA2627477A1 Novel beta-agonists, process for their preparation and their use as medicaments |
| 05/03/2007 | CA2627463A1 Anti mineralocorticoid therapy of infection |
| 05/03/2007 | CA2627419A1 Novel method for preparing quaternary acid and ammonium salts |
| 05/03/2007 | CA2627403A1 Imidazo-pyridine containing beta agonists, method for producing them and their use as drugs |
| 05/03/2007 | CA2627323A1 Compositions for- detecting of influenza viruses and kits and methods using same |
| 05/03/2007 | CA2627303A1 Agent for treatment of circulatory failure |
| 05/03/2007 | CA2627268A1 Process for the preparation of sour cherry seed extract, use of the extract for the preparation of pharmaceutical compositions and pharmaceutical compositions containing said extract |
| 05/03/2007 | CA2627240A1 Alkoxyalkyl spirocyclic tetramic acids and tetronic acids |
| 05/03/2007 | CA2627234A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/03/2007 | CA2627223A1 Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate |
| 05/03/2007 | CA2627215A1 Ophthalmic pharmaceutical compositions comprising amino acids and sodium hyaluronate |
| 05/03/2007 | CA2627214A1 Topical pharmaceutical compositions comprising amino acids and sodium hyaluronate |
| 05/03/2007 | CA2627211A1 Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors |
| 05/03/2007 | CA2627139A1 Novel benzoxathiin derivative |
| 05/03/2007 | CA2627105A1 Influenza combinatorial antigen vaccine |
| 05/03/2007 | CA2627090A1 Benzimidazole derivatives for use as beta-3 receptor agonists |
| 05/03/2007 | CA2627025A1 Compositions and methods for inhibiting expression of huntingtin gene |
| 05/03/2007 | CA2627000A1 Small interfering ribonucleic acid duplexes comprising arabinose modified nucleotides |
| 05/03/2007 | CA2626997A1 Analogs of alpha galactosylceramide and uses thereof |
| 05/03/2007 | CA2626976A1 Heterocyclic aspartyl protease inhibitors |
| 05/03/2007 | CA2626975A1 8-[bis-(2-chloro-phenyl)-methyl]-3-phenyl-8-aza-bicyclo [3.2.1] octane-3-carboxylic acid amide as ligand for the nociceptin receptor orl-1 |
| 05/03/2007 | CA2626956A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity |
| 05/03/2007 | CA2626928A1 A 4-oxo-1- (3-substituted phenyl) -1, 4-dihydro-1, 8-naphthyridine-3-carboxamide phosphodiesterase-4-inhibitor and a method of preparing same |
| 05/03/2007 | CA2626865A1 Macromolecular compounds having controlled stoichiometry |
| 05/03/2007 | CA2626747A1 (hetero)aryl compounds with mch antagonistic activity and medicaments comprising these compounds |
| 05/03/2007 | CA2626593A1 Indazole derivatives that inhibit trpv1 receptor |
| 05/03/2007 | CA2626579A1 Formulation comprising a drug of low water solubility and method of use thereof |
| 05/03/2007 | CA2626565A1 Piperazine derivatives useful as ccr5 antagonists |
| 05/03/2007 | CA2626547A1 The induction of indoleamine 2,3-dioxygenase in dendritic cells by tlr ligands and uses thereof |
| 05/03/2007 | CA2626496A1 Potassium channel inhibitors |
| 05/03/2007 | CA2626394A1 Yeast cell wall particle for delivering osteoprotegerin-encoding polynucleotide |
| 05/03/2007 | CA2626375A1 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
| 05/03/2007 | CA2626324A1 Arylurea derivatives as modulators of chemokine receptor activity |
| 05/03/2007 | CA2626303A1 Sexual desire enhancing medicaments comprising benzimidazolone derivatives |
| 05/03/2007 | CA2626208A1 Topical pharmaceutical foam composition |
| 05/03/2007 | CA2626190A1 Derivatives for modulation of ion channels |
| 05/03/2007 | CA2626180A1 Tricyclic compounds useful as oxytocin receptor agonists |
| 05/03/2007 | CA2626134A1 Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
| 05/03/2007 | CA2625969A1 Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease |
| 05/03/2007 | CA2625966A1 Combination of histone deacetylase inhibitors and radiation |
| 05/03/2007 | CA2625676A1 Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist |
| 05/03/2007 | CA2625673A1 Hiv integrase inhibitors |
| 05/03/2007 | CA2625541A1 Ppar modulating biaromatic compounds |
| 05/03/2007 | CA2624656A1 Tyrosine kinase inhibitors |
| 05/03/2007 | CA2624383A1 Salts of modulators of ppar and methods of treating metabolic disorders |
| 05/03/2007 | CA2624353A1 Tyrosine kinase inhibitors |
| 05/03/2007 | CA2624221A1 Preventives/remedies for cancer |
| 05/03/2007 | CA2623879A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 05/03/2007 | CA2623838A1 Extract of the family dioscoreaceae and composition for preventing or treating peripheral neuropathy comprising the same |
| 05/03/2007 | CA2623360A1 Squaric acid derivatives as inhibitors of histone deacetylase |
| 05/03/2007 | CA2623160A1 Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists |
| 05/03/2007 | CA2622600A1 Rxr agonists and antagonists, alone or in combination with ppar ligands, in the treatment of metabolic and cardiovascular diseases |
| 05/03/2007 | CA2616416A1 Trazodone composition for once a day adminisitiation |
| 05/03/2007 | CA2616204A1 Sustained drug release composition |
| 05/03/2007 | CA2614345A1 Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same |
| 05/03/2007 | CA2604404A1 An improved process for preparation of irbesartan |
| 05/02/2007 | EP1780278A2 Mammalian calcium channels and related probes, cell lines and methods |
| 05/02/2007 | EP1780214A2 Combinatorial production of nucleotide and nucleoside analogues (XiTP) |
| 05/02/2007 | EP1780212A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE |
| 05/02/2007 | EP1780210A1 Novel cyclic aminobenzoic acid derivative |
| 05/02/2007 | EP1780207A2 Crystalline esomeprazole strontium hydrate, method for preparing the same and pharmaceutical composition containing the same |
| 05/02/2007 | EP1780201A2 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 05/02/2007 | EP1780197A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1779900A1 Cosmetic or dermatological composition for prevention of light-induced aging |
| 05/02/2007 | EP1779867A1 Nerve reveneration promoter |
| 05/02/2007 | EP1779863A1 Use of TGF-Beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa |
| 05/02/2007 | EP1779854A1 Glycyrrhizin-containing suppository compositions for rectal infusion |
| 05/02/2007 | EP1779853A2 9a-azalides as veterinary antimicrobial agents |
| 05/02/2007 | EP1779852A2 Methods for the production of sildenafil base and citrate salt |
| 05/02/2007 | EP1779851A1 Treatment of diabetes |
| 05/02/2007 | EP1779850A1 Tgf- gene expression inhibitor |
| 05/02/2007 | EP1779849A1 V-ATPase inhibitors for the treatment of septic shock |
| 05/02/2007 | EP1779848A1 V-ATPase inhibitors for the treatment of inflammatory and autoimmune diseases |
| 05/02/2007 | EP1778861A2 Methods and kits for predicting liver fibrosis progression rate in chronic hepatitis c patients |
| 05/02/2007 | EP1778715A2 Compounds and their preparation for the treatment of alzheimer's disease by inhibiting beta-amyloid peptide production |
| 05/02/2007 | EP1778712A2 2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity |
| 05/02/2007 | EP1778710A1 Tanaproget derivatives, metabolites, and uses thereof |
| 05/02/2007 | EP1778709A2 Polysulfated glycosides and salts thereof |
| 05/02/2007 | EP1778702A2 Antiviral compounds |
| 05/02/2007 | EP1778699A2 Targeting chelants and chelates |
| 05/02/2007 | EP1778697A1 Substituted bicyclic 8-pyrrolidino-xanthines and use thereof as inhibitors of the dipeptidyl peptidase iv |
| 05/02/2007 | EP1778696A2 (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors |
| 05/02/2007 | EP1778694A1 Tetrahydroquinolines |
| 05/02/2007 | EP1778693A2 Tricyclic-heteroaryl compounds useful as kinase inhibitors |
| 05/02/2007 | EP1778692A2 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane |
| 05/02/2007 | EP1778691A1 Hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl)-benzamide, methods for the production thereof, and use thereof as medicaments |
| 05/02/2007 | EP1778690A1 Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments |
| 05/02/2007 | EP1778689A1 Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv |
| 05/02/2007 | EP1778688A1 Antibacterial agents |
| 05/02/2007 | EP1778687A2 Fused ring heterocycle kinase modulators |
| 05/02/2007 | EP1778686A2 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors |
| 05/02/2007 | EP1778685A1 Indolizine carboxamides and the aza and diaza derivatives thereof |
| 05/02/2007 | EP1778684A1 4-PIPERAZINYL-PYRIMIDINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D<sb>3</sb> RECEPTOR |
| 05/02/2007 | EP1778683A1 Thiophene derivatives, their manufacture and use as pharmaceutical agents |
| 05/02/2007 | EP1778682A1 Heterocyclic compounds useful as dpp- iv inhibitors |